Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Differential binding patterns of anti-sulfatide antibodies to glial membranes.

Meehan GR, McGonigal R, Cunningham ME, Wang Y, Barrie JA, Halstead SK, Gourlay D, Yao D, Willison HJ.

J Neuroimmunol. 2018 Oct 15;323:28-35. doi: 10.1016/j.jneuroim.2018.07.004. Epub 2018 Jul 9.

2.

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

Davidson AI, Halstead SK, Goodfellow JA, Chavada G, Mallik A, Overell J, Lunn MP, McConnachie A, van Doorn P, Willison HJ.

J Peripher Nerv Syst. 2017 Mar;22(1):4-12. doi: 10.1111/jns.12194.

PMID:
27801990
3.

Microarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes.

Halstead SK, Kalna G, Islam MB, Jahan I, Mohammad QD, Jacobs BC, Endtz HP, Islam Z, Willison HJ.

Neurol Neuroimmunol Neuroinflamm. 2016 Sep 28;3(6):e284. eCollection 2016 Dec.

4.

Anti-ganglioside antibodies are removed from circulation in mice by neuronal endocytosis.

Cunningham ME, McGonigal R, Meehan GR, Barrie JA, Yao D, Halstead SK, Willison HJ.

Brain. 2016 Jun;139(Pt 6):1657-65. doi: 10.1093/brain/aww056. Epub 2016 Mar 26.

5.

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, Vial AL, Decam C, Choumet V, Halstead SK, Willison HJ, Musset L, Manuguerra JC, Despres P, Fournier E, Mallet HP, Musso D, Fontanet A, Neil J, Ghawché F.

Lancet. 2016 Apr 9;387(10027):1531-1539. doi: 10.1016/S0140-6736(16)00562-6. Epub 2016 Mar 2.

6.

The Diagnostic Utility of Determining Anti-GM1: GalC Complex Antibodies in Multifocal Motor Neuropathy: A Validation Study.

Galban-Horcajo F, Vlam L, Delmont E, Halstead SK, van den Berg L, van der Pol WL, Willison HJ.

J Neuromuscul Dis. 2015 Jun 4;2(2):157-165.

7.

The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders.

Galban-Horcajo F, Halstead SK, McGonigal R, Willison HJ.

Curr Opin Chem Biol. 2014 Feb;18:78-86. doi: 10.1016/j.cbpa.2014.01.008. Epub 2014 Feb 2. Review.

PMID:
24495749
8.

Antibodies to GM1: galactocerebroside complexes in multifocal motor neuropathy: it takes two to tango.

Willison HJ, Galban-Horcajo F, Halstead SK.

J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):715. doi: 10.1136/jnnp-2013-306050. Epub 2013 Sep 4. No abstract available.

PMID:
24006050
9.

Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: an in and ex vivo imaging study in the mouse.

Rupp A, Morrison I, Barrie JA, Halstead SK, Townson KH, Greenshields KN, Willison HJ.

Exp Neurol. 2012 Feb;233(2):836-48. doi: 10.1016/j.expneurol.2011.12.010. Epub 2011 Dec 16.

PMID:
22197826
10.

Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice.

McGonigal R, Rowan EG, Greenshields KN, Halstead SK, Humphreys PD, Rother RP, Furukawa K, Willison HJ.

Brain. 2010 Jul;133(Pt 7):1944-60. doi: 10.1093/brain/awq119. Epub 2010 May 30.

11.

The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice.

Greenshields KN, Halstead SK, Zitman FM, Rinaldi S, Brennan KM, O'Leary C, Chamberlain LH, Easton A, Roxburgh J, Pediani J, Furukawa K, Furukawa K, Goodyear CS, Plomp JJ, Willison HJ.

J Clin Invest. 2009 Mar;119(3):595-610. doi: 10.1172/JCI37338. Epub 2009 Feb 16.

12.

C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome.

Halstead SK, Humphreys PD, Zitman FM, Hamer J, Plomp JJ, Willison HJ.

J Peripher Nerv Syst. 2008 Sep;13(3):228-35. doi: 10.1111/j.1529-8027.2008.00181.x.

PMID:
18844789
13.

The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barré syndrome.

Willison HJ, Halstead SK, Beveridge E, Zitman FM, Greenshields KN, Morgan BP, Plomp JJ.

J Neuroimmunol. 2008 Sep 15;201-202:172-82. doi: 10.1016/j.jneuroim.2008.05.028. Epub 2008 Jul 29. Review.

PMID:
18664403
14.

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

Halstead SK, Zitman FM, Humphreys PD, Greenshields K, Verschuuren JJ, Jacobs BC, Rother RP, Plomp JJ, Willison HJ.

Brain. 2008 May;131(Pt 5):1197-208. doi: 10.1093/brain/awm316. Epub 2008 Jan 8.

PMID:
18184663
15.

Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome.

Halstead SK, Humphreys PD, Goodfellow JA, Wagner ER, Smith RA, Willison HJ.

Ann Neurol. 2005 Aug;58(2):203-10.

PMID:
16049921
16.

Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions.

Halstead SK, Morrison I, O'Hanlon GM, Humphreys PD, Goodfellow JA, Plomp JJ, Willison HJ.

Glia. 2005 Nov 15;52(3):177-89.

PMID:
15968629
17.

Concanavalin A inhibits pathophysiological effects of anti-ganglioside GQ1b antibodies at the mouse neuromuscular synapse.

Bullens RW, Halstead SK, O'Hanlon GM, Veitch J, Molenaar PC, Willison HJ, Plomp JJ.

Muscle Nerve. 2005 Jun;31(6):751-60.

PMID:
15793847
18.

Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.

Goodfellow JA, Bowes T, Sheikh K, Odaka M, Halstead SK, Humphreys PD, Wagner ER, Yuki N, Furukawa K, Furukawa K, Plomp JJ, Willison HJ.

J Neurosci. 2005 Feb 16;25(7):1620-8.

19.

Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.

Halstead SK, O'Hanlon GM, Humphreys PD, Morrison DB, Morgan BP, Todd AJ, Plomp JJ, Willison HJ.

Brain. 2004 Sep;127(Pt 9):2109-23. Epub 2004 Aug 2.

PMID:
15289269
20.

Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury.

O'Hanlon GM, Humphreys PD, Goldman RS, Halstead SK, Bullens RW, Plomp JJ, Ushkaryov Y, Willison HJ.

Brain. 2003 Nov;126(Pt 11):2497-509. Epub 2003 Aug 22.

PMID:
12937083
21.

Integration of formulary systems with centralized pharmaceutical procurement.

Smith EB Jr, Hope SM, Halstead SK, Ford WM.

Hosp Formul. 1990 Feb;25(2):193-6, 198.

PMID:
10170504

Supplemental Content

Loading ...
Support Center